Recce Pharmaceuticals has signed an exclusive licensing and commercialization agreement with Arrotex Pharmaceuticals for its RECCE 327 topical gel targeting diabetic foot infections in Australia and New Zealand. Arrotex will handle regulatory filings, reimbursement, sales, and marketing, while Recce retains intellectual property rights and manufacturing responsibilities. The gel is in Phase 3 clinical trials and awaits regulatory approval, with Arrotex required to seek approval from Australia's Therapeutic Goods Administration after approvals from recognized overseas regulators. This deal establishes a clear path to market for Recce's treatment, combining Recce's development expertise with Arrotex's regional commercial capabilities.
Recce Pharmaceuticals' licensing deal with Arrotex for RECCE 327 provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 22, 2026 05:41 WIB: out of 150 priced health-sector US stocks, 71 rose and 77 fell. Notable movers include ROIV at USD 36.90 with a 5.67% gain and TXG at USD 75.50 with a 5.65% gain, both showing 100% buy order activity on Pluang.
Senteon was awarded the Best Solution Patch and Configuration Management at the 2026 Top InfoSec Innovator Awards by Cyber Defense Magazine. The company’s platform automates endpoint hardening and continuously monitors security configurations to redu...
RENK Group AG has sold its slide bearings business to Austrian company Miba AG to sharpen its focus on the defense sector, aiming to increase defense-related revenue to 90% by 2030. The sale does not affect RENK's Marine & Industry civilian business,...
RENK Group AG is selling its slide bearings business to Austrian company Miba AG as part of a strategic shift to focus more on its defense sector. The sale supports RENK's plan to increase defense-related revenue to about 90% by 2030, while the civil...
RENK Group AG, through its subsidiary RENK GmbH, has signed a binding agreement to sell its Slide Bearings business to Austria's Miba AG. The Slide Bearings segment produces standardized bearings used mainly in industrial and civil markets. This sale...
RENK Group AG, through its subsidiary RENK GmbH, has signed a binding agreement to sell its Slide Bearings business to Austria's Miba AG. This unit produces slide bearings mainly used in industrial and civilian markets. The sale aligns with RENK's 20...
